Posted On: 12/07/2013 2:32:21 PM
Post# of 63839

From Pharma PRs

- Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
1:30 pm - PR Newswire Saturday 7th
SYN Chart

